AstraZeneca Will Require Submission of Claims Data to 340B ESP™ for Covered Entities to Designate Single Contract Pharmacy

Beginning October 1, 2024, AstraZeneca will require all covered entities to submit 340B claims utilization data to ESP™ as a pre-requisite for designating a single contract pharmacy.  This announcement, released…